Kathy Sapp, the new CEO of the American Chronic Pain Association (ACPA) is President and Co-founder of Patient Mind Inc., a 501c(3) organization on a mission to improve clinical dialogue by eliminating the knowledge gap between clinicians and patients. Prior to forming Patient Mind Inc. in the state of Kansas in 2017, Kathy spent the majority of her career in the Pharmaceutical Industry. Those companies included Marion Labs, Marion Merrell Dow, Hoechst Marion Roussel, Aventis, Pharmion Corporation, and Teva Pharmaceuticals. She was responsible for forging alliances with hundreds of national and international advocacy organizations and other third parties to enact mutually beneficial strategies and meet business and patient needs. She managed hundreds of advisory boards on a global basis, building strong relationships with advocacy organizations and KOL’s. Her established relationships with key customers included rare diseases (Huntington’s, Aplastic Anemia, Multiple Myeloma), Bipolar Disorder, Diabetes, CV, Neurology (Pain, Migraine, MS, Epilepsy, Narcolepsy), and Oncology. She evaluated and supported thousands of medical and patient education grant and sponsorship requests, developed collaborative agreement opportunities, and built strategic advocacy plans. She tightly managed million dollar budgets. As a health advocate for patients, her sponsorship of innovative and award winning programs supported millions of patients globally to engage in their health care rights.
Kathy earned her BS in Business Administration from Avila University (Kansas City, Missouri)